Pharmacological conversion of recent-onset atrial fibrillation: a systematic review.
about
The vernakalant story: how did it come to approval in Europe and what is the delay in the U.S.A?New-onset atrial fibrillation in critically ill patients.Amiodarone Versus Propafenone to Treat Atrial Fibrillation after Coronary Artery Bypass Grafting: A Randomized Double Blind Controlled Trial.Ranolazine enhances the antiarrhythmic activity of amiodarone by accelerating conversion of new-onset atrial fibrillation after cardiac surgery.2017 EACTS Guidelines on perioperative medication in adult cardiac surgery.Prise en charge de la fibrillation atriale en médecine d’urgence. Recommandations de la Société française de médecine d’urgence en partenariat avec la Société française de cardiologie
P2860
Pharmacological conversion of recent-onset atrial fibrillation: a systematic review.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Pharmacological conversion of recent-onset atrial fibrillation: a systematic review.
@en
type
label
Pharmacological conversion of recent-onset atrial fibrillation: a systematic review.
@en
prefLabel
Pharmacological conversion of recent-onset atrial fibrillation: a systematic review.
@en
P2860
P1476
Pharmacological conversion of recent-onset atrial fibrillation: a systematic review.
@en
P2093
Magnus Heldal
P2860
P356
10.3109/14017431.2012.740572
P577
2012-11-13T00:00:00Z